Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 70,78
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 78,85
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 9.18x6.12 inches. In Stock.
Zustand: New. Ruixiao LuDr. Ruixiao Lu is a recognized leader in the biotech and biopharma industry, currently serving as Vice President, Head of Biostatistics & Statistical Programming at Alumis Inc. She has held senior leadership roles at various c.
Sprache: Englisch
Verlag: Taylor & Francis Ltd Mai 2026, 2026
ISBN 10: 1032544546 ISBN 13: 9781032544540
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - Drug development is at a crossroads. As personalized medicine and targeted therapies expand, traditional clinical trial models have become too slow, costly, and inefficient. To meet the urgent need for faster, reliable evidence generation and decision making, researchers and regulators alike have turned to innovative trial designs. Among these, master protocols stand out as a transformative approach, allowing multiple therapies, disease subtypes, or objectives to be studied under a single, integrated framework. Proven successful in oncology, COVID-19, and beyond, they improve efficiency, reduce participant exposure to ineffective treatments, and accelerate meaningful outcomes with patient centric approach, prompting regulatory guidance and global adoption.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Master Protocol Clinical Trials for Evidence Generation | Strategies, Designs, Operations, and Case Studies | Chengxing Lu (u. a.) | Taschenbuch | Chapman & Hall/CRC Biostatistics Series | Einband - flex.(Paperback) | Englisch | 2026 | Taylor & Francis Ltd | EAN 9781032544540 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 183,58
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
EUR 170,17
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Ruixiao LuDr. Ruixiao Lu is a recognized leader in the biotech and biopharma industry, currently serving as Vice President, Head of Biostatistics & Statistical Programming at Alumis Inc. She has held senior leadership roles at various c.
Sprache: Englisch
Verlag: Taylor & Francis Ltd Mai 2026, 2026
ISBN 10: 103254452X ISBN 13: 9781032544526
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Drug development is at a crossroads. As personalized medicine and targeted therapies expand, traditional clinical trial models have become too slow, costly, and inefficient. To meet the urgent need for faster, reliable evidence generation and decision making, researchers and regulators alike have turned to innovative trial designs. Among these, master protocols stand out as a transformative approach, allowing multiple therapies, disease subtypes, or objectives to be studied under a single, integrated framework. Proven successful in oncology, COVID-19, and beyond, they improve efficiency, reduce participant exposure to ineffective treatments, and accelerate meaningful outcomes with patient centric approach, prompting regulatory guidance and global adoption.